The presence of tumor stem cells in primary HCC was confirmed with in-depth studies of the tumor stem cell doctrine, and CD133 is a tumor stem cell marker for radiotherapy and chemotherapy resistance. This evidence concerns the gene PROM1 and hepatocellular carcinoma.